RI.MOS

What RI.MOS does

RI.MOS. srl is a privately held Italian medical device and plant-based product manufacturer founded in 1988, headquartered in Mirandola (Province of Modena, Emilia-Romagna) within Italy's biomedical district. The company operates three divisions: MED (single-use medical devices for gynecology, obstetrics, assisted reproduction, and mesotherapy under the Ginram, Fertiram, Mesoram, TURTLEPIN, and V-STORK brands), CARE (Class IIb plant-based interactive wound dressings and functional cosmetics, including Hyperoil, MYKUTIS, and PURO H), and VET (plant-based veterinary wound care, CBD-based wellness products, phytocomplex formulations, and intradermal microinjection devices under the Hypermix, Kanarescue, and PHYTOFORMULAVET brands, with carevix as a recent cervical stabilizer launch). Core technology includes electrospinning for sub-micrometric PLLA fiber non-woven fabrics used in MYKUTIS skin substitutes, and proprietary extraction processes for Hypericum perforatum and Neem (Azadirachta indica). All single-use devices are assembled in ISO 8 cleanrooms under an ISO 13485 quality system with CE marking under EU MDR 2017/745 and DIR 93/42/EEC.

The business model is B2B-direct plus distributor-mediated export. In Italy, RI.MOS. operates a direct sales force covering healthcare professionals, clinics, hospitals, and veterinarians, with quote-based pricing, volume discounts, no minimum order quantities, and free samples for sub-€5 products. Internationally, the company exports to over 80 countries through independent distributors and participates in trade collectives such as the Japan Health 2025 Italian Collective. Direct-to-consumer sales occur via two dedicated e-commerce storefronts (rimoscare.com for human products, rimosvet.com for veterinary products), and OEM/private label manufacturing services are offered. Revenue is generated from one-time device sales across all three divisions plus the OEM licensing stream; recurring revenue characteristics exist where consumables drive repeat orders. Revenue figures, headcount, and ownership are not publicly disclosed. Share capital is €118,500, and no external investors, subsidiaries, or M&A activity are reported.

Name

RI.MOS

Legal name

RI.MOS. srl

Website

https://rimos.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

11–50 employees

Short description

RI.MOS. is an Italian medical device and plant-based product manufacturer (founded 1988, Mirandola) operating three divisions — disposable medical devices for gynecology/obstetrics (MED), plant-based wound care and dermocosmetics (CARE), and veterinary products including intradermal microinjection devices (VET) — exporting CE-marked, ISO 13485-certified products to over 80 countries.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391), Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)

akta.pro secondary industries

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers) (HLAMAFAF)

Keywords

• Disposable medical devices
• Gynecological instruments
• Wound care dressings
• Plant-based cosmetics
• Veterinary wound care

Headquarters

HQ city

Modena

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Disposable Medical Devices Sales (MED Division): Sales of CE-marked disposable medical devices for gynecology, obstetrics, mesotherapy, and assisted reproduction. Products include Ginram® (gynecology/obstetrics), Fertiram® (assisted fertilization), Mesoram® (mesotherapy/microinjection), and related consumables. Revenue generated through direct sales, distributor network, and e-commerce channels.
2. Medical Devices and Dermocosmetics (CARE Division): Sales of plant-based medical devices (Hyperoil®, MYKUTIS®) and functional cosmetics (PURO H®) for wound care, dermatology, and skincare. Products available through e-commerce (rimoscare.com) and professional channels.
3. Veterinary Products (VET Division): Sales of plant-based veterinary products including Hypermix® (wound care), Kanarescue® (CBD-based products), PHYTOFORMULAVET®, and intradermal microinjection devices. Distributed through veterinarians, specialist distributors, and e-commerce (rimosvet.com). OEM/customization services available for Hypermix® line.
4. OEM/Private Label Manufacturing: RI.MOS. offers OEM services providing certified development, customization, and production for medical devices, functional cosmetics, and topical herbal treatments. Particularly available for the Hypermix® veterinary line.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

RI.MOS. designs, manufactures, and sells disposable single-use medical devices for gynecology, obstetrics, assisted reproduction, and mesotherapy/microinjection under its MED division; plant-based Class IIb medical devices (Hyperoil®, MYKUTIS®) and functional cosmetics (PURO H®) for wound care and dermatology under its CARE division; and plant-based veterinary wound care products (Hypermix®), CBD-based animal wellness products (Kanarescue®), phytocomplex nutritional products (PHYTOFORMULAVET®), and intradermal microinjection devices under its VET division. The company also offers OEM/private-label manufacturing services for partners requiring certified development and production of plant-based medical devices and cosmetics.

Product overview

RI.MOS. is an Italian medical device manufacturer founded in 1988 with three product divisions: MED (single-use medical devices for gynecology, obstetrics, and assisted reproduction including Ginram®, Fertiram®, and Mesoram® brands), CARE (plant-based medical devices and dermocosmetics for wound care including Hyperoil®, MYKUTIS®, and PURO H®), and VET (veterinary products including Hypermix®, Kanarescue®, PHYTOFORMULAVET®, and intradermal microinjection devices). The company exports Made in Italy products to over 80 countries, operates ISO 8 cleanrooms, and holds ISO 13485 certification with CE marking on all products.

Differentiator

Problem solved

Functional benefit

Brands

• MED: Division dedicated to disposable medical devices for gynecology, obstetrics, mesotherapy, and assisted reproduction.
• CARE
• VET
• Ginram®
• Fertiram®
• Mesoram®
• Hyperoil®
• MYKUTIS®
• PURO H®
• Hypermix®
• Kanarescue®
• PHYTOFORMULAVET®
• V-STORK
• TURTLEPIN®
• carevix®

Products and services

• GINRAM® Single-Use Medical Devices for Gynecology and Obstetrics

Quantifiable outcome

• Products proven safe through biocompatibility and stability testing
• +2 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Confindustria Emilia Area CentrominorOthersRI.MOS. is an associate member of Confindustria Emilia Area Centro, the regional employers' association representing industrial companies in the area of Modena and Reggio Emilia.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• B. Braun: B. Braun is a broad medical device and disposables incumbent with single-use surgical and gynecological devices that overlap with RI.MOS.'s Ginram® and Mesoram® lines. It offers a much wider portfolio across IV therapy, surgery, and clinical care.
• Coloplast: Coloplast is a major wound care and ostomy company whose Biatain and Comfeel dressings compete with RI.MOS.'s Hyperoil® in chronic wound management. As a broad incumbent, it offers overlapping capabilities across multiple wound and skin care segments.
• Dechra Veterinary Products: Dechra is a global veterinary pharmaceuticals and dermatology company. Its topical dermatology and wound care portfolio competes with RI.MOS.'s Hypermix® and Kanarescue® lines, while offering broader therapeutic coverage across companion animal health.
• Paul Hartmann: Paul Hartmann is a European wound care and hygiene incumbent (Cosmopor, Atrauman). Its wound management portfolio competes with RI.MOS.'s Hyperoil® dressings, while its broader hygiene and disinfection business partially overlaps with the company's plant-based and single-use device offerings.
• Smith & Nephew: Smith & Nephew's Advanced Wound Management division is a broad incumbent in wound care and skin substitutes, with deeper clinical evidence and global hospital reach than RI.MOS. It competes across the same wound care segments while serving a much wider surgical portfolio.

Direct peers

• Vetoquinol: Vetoquinol is a global animal health company with a strong dermatology and topical care portfolio. It competes directly with RI.MOS.'s VET division, particularly with the Hypermix® wound care line and Kanarescue® topical CBD products.
• Urgo Medical: Urgo Medical is a wound care specialist with a portfolio of interactive dressings (UrgoStart, Urgocell). Its TLC-NOSF technology competes in the same advanced wound dressing category as RI.MOS.'s plant-based Hyperoil® offerings.
• ConvaTec: ConvaTec is a major wound and skin care company whose portfolio of advanced dressings (Aquacel, DuoDERM) overlaps directly with RI.MOS.'s plant-based Hyperoil® and MYKUTIS® products in the chronic wound and post-surgical care market.
• Mölnlycke Health Care: Mölnlycke is a global wound care leader (Mepilex, Mepitel, etc.). Its advanced wound dressings compete directly with RI.MOS.'s Hyperoil® and MYKUTIS® interactive wound care line, serving the same hospital and specialty wound care buyers.
• CooperSurgical: CooperSurgical is a leading global manufacturer of women's health, fertility, and assisted reproduction devices. It directly overlaps with RI.MOS.'s Ginram® (gynecology/obstetrics) and Fertiram® (ART) product lines, serving the same clinical specialties with comparable disposable medical devices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/RIMOS.ITALY
• LinkedInlinkedin.com/company/ri.mos.-s.r.l.
• Instagraminstagram.com/ri.mos_italy

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RI.MOS